Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells

Pancreas

Volumn 40, Issue 7, 2011, Pages 1107-1119

  Veeraraghavan, Jamunarani ^a   Natarajan, Mohan ^b   Lagisetty, Pallavi ^c   Awasthi, Vibhudutta ^c   Herman, Terence S ^a   Aravindan, Natarajan ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

curcumin; neem; NF B; pancreatic cancer; radiosensitization; raspberry

Indexed keywords

AZADIRACHTA INDICA EXTRACT; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLANT EXTRACT; RASPBERRY EXTRACT; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; DNA BINDING; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; PANCREAS CANCER; PLANT LEAF; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIZATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; AZADIRACHTA; CELL LINE, TUMOR; CURCUMIN; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FRUIT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B P50 SUBUNIT; PANCREATIC NEOPLASMS; PLANT EXTRACTS; PLANT LEAVES; RADIATION-SENSITIZING AGENTS; ROSACEAE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTOR RELA; TRANSFECTION;

EID: 80052965034     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31821f677d     Document Type: Article

References (47)

1. American Cancer Society. Cancer Facts & Figures 2010. Atlanta, GA: American Cancer Society; 2010.
2. Kern SE, Shi C, Hruban RH. The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting. J Pathol. 2011;223(2):296-307.
3. Bayraktar S, Rocha-Lima CM. Advanced or metastatic pancreatic cancer: Molecular targeted therapies. Mt Sinai J Med. 2010;77: 606-619.
4. Sun V. Update on pancreatic cancer treatment. Nurse Pract. 2010;35: 16-22.
5. Willett CG, Czito BG, Bendell JC, et al. Locally advanced pancreatic cancer. J Clin Oncol. 2005;23:4538-4544. (Pubitemid 46196584)
6. Lockhart AC, Rothenberg ML, Berlin JD. Treatment for pancreatic cancer: Current therapy and continued progress. Gastroenterology. 2005;128:1642-1654. (Pubitemid 40692557)
7. Dobelbower RR Jr, Milligan AJ. Treatment of pancreatic cancer by radiation therapy. World J Surg. 1984;8:919-928. (Pubitemid 15024915)
8. Sawaki A, Hoki N, Ito S, et al. Clinical impact of radiotherapy for locally advanced pancreatic cancer. J Gastroenterol. 2009;44:1209-1214.
9. Hendry JH, West CM. Apoptosis and mitotic cell death: Their relative contributions to normal-tissue and tumour radiation response. Int J Radiat Biol. 1997;71:709-719. (Pubitemid 27306026)
10. Asanuma K, Moriai R, Yajima T, et al. Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res. 2000;91:1204-1209.
11. Shibamoto Y, Kubota T, Kishii K, et al. Radiosensitivity of human pancreatic cancer cells in vitro and in vivo, and the effect of a new hypoxic cell sensitizer, doranidazole. Radiother Oncol. 2000;56:265-270. (Pubitemid 30601686)
12. Lee JU, Hosotani R, Wada M, et al. Role of bcl-2 family proteins (bax, bcl-2 and bcl-x) on cellular susceptibility to radiation in pancreatic cancer cells. Eur J Cancer. 1999;35:1374-1380. (Pubitemid 29397439)
13. Baeuerle PA, Baltimore D. Hormonal control regulation of gene transcription. In: Cohen P, Foulkes JG, eds. Molecular Aspects of Cellular Regulation. Amsterdam, The Netherlands: Elsevier/North Holland Biomedical Press; 1991:409-432.
14. Lenardo MJ, Baltimore D. NFJB: A pleiotropic mediator of inducible and tissue-specific gene control. Cell. 1989;58:227-229. (Pubitemid 19191405)
15. Neri A, Chang CC, Lombardi L, et al. B cell lymphomaYassociated chromosomal translocation involves candidate oncogene lyt-10, homologous to NFJB p50. Cell. 1991;67:1075-1087. (Pubitemid 121001521)
16. Yeoh A, Gibson R, Yeoh E, et al. Radiation therapyYinduced mucositis: Relationships between fractionated radiation, NFJB, cox-1, and cox-2. Cancer Treat Rev. 2006;32:645-651. (Pubitemid 44645028)
17. Higgins KA, Perez JR, Coleman TA, et al. Antisense inhibition of the p65 subunit of NFJB blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci U S A. 1993;90:9901-9905. (Pubitemid 23328218)
18. Tozawa K, Sakurada S, Kohri K, et al. Effects of antiYnuclear factor JB reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res. 1995;55:4162-4167.
19. Aravindan N, Madhusoodhanan R, Natarajan M, et al. Alteration of apoptotic signaling molecules as a function of time after radiation in human neuroblastoma cells. Mol Cell Biochem. 2008;310:167-179.
20. Madhusoodhanan R, Natarajan M, Veeraraghavan J, et al. NFJB activity and transcriptional responses in human breast adenocarcinoma cells after single and fractionated irradiation. Cancer Biol Ther. 2009;8: 765-773.
21. Madhusoodhanan R, Natarajan M, Veeraraghavan J, et al. NFJB signaling related molecular alterations in human neuroblastoma cells after fractionated irradiation. J Radiat Res (Tokyo). 2009;50: 311-324.
22. Aravindan N, Madhusoodhanan R, Ahmad S, et al. Curcumin inhibits NFJB mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells. Cancer Biol Ther. 2008;7:569-576. (Pubitemid 351847033)
23. Chandler NM, Canete JJ, Callery MP. Increased expression of NFJB subunits in human pancreatic cancer cells. J Surg Res. 2004;118:9-14. (Pubitemid 38490509)
24. Sclabas GM, Uwagawa T, Schmidt C, et al. Nuclear factor JB activation is a potential target for preventing pancreatic carcinoma by aspirin. Cancer. 2005;103:2485-2490. (Pubitemid 40800526)
25. Liptay S, Weber CK, Ludwig L, et al. Mitogenic and antiapoptotic role of constitutive NFJB/rel activity in pancreatic cancer. Int J Cancer. 2003;105:735-746. (Pubitemid 36706095)
26. Sclabas GM, Fujioka S, Schmidt C, et al. Restoring apoptosis in pancreatic cancer cells by targeting the nuclear factor-JB signaling pathway with the antiYepidermal growth factor antibody imc-c225. J Gastrointest Surg. 2003;7:37-43; discussion 43. (Pubitemid 36875799)
27. Fujioka S, Sclabas GM, Schmidt C, et al. Inhibition of constitutive NFJB activity by IJB alpha m suppresses tumorigenesis. Oncogene. 2003;22:1365-1370. (Pubitemid 36384598)
28. Fujioka S, Sclabas GM, Schmidt C, et al. Function of nuclear factor JB in pancreatic cancer metastasis. Clin Cancer Res. 2003;9:346-354. (Pubitemid 36109751)
29. Madhusoodhanan R, Natarajan M, Veeraraghavan J, et al. Effect of black raspberry extract in inhibiting NFJB dependent radioprotection in human breast cancer cells. Nutr Cancer. 2010;62:93-104.
30. Chattopadhyay RR. Possible biochemical mode of anti-inflammatory action of azadirachta indica a. Juss. In rats. Indian J Exp Biol. 1998;36:418-420.
31. Akudugu J, Gade G, Bohm L. Cytotoxicity of azadirachtin a in human glioblastoma cell lines. Life Sci. 2001;68:1153-1160. (Pubitemid 32168041)
32. Roy MK, Kobori M, Takenaka M, et al. Antiproliferative effect on human cancer cell lines after treatment with nimbolide extracted from an edible part of the neem tree (Azadirachta indica). Phytother Res. 2007;21:245-250. (Pubitemid 46479675)
33. Aravindan N, Natarajan M, Shaw AD. Fenoldopam inhibits nuclear translocation of nuclear factor JB in a rat model of surgical ischemic acute renal failure. J Cardiothorac Vasc Anesth. 2006;20:179-186.
34. Tang Y, Lu A, Aronow BJ, et al. Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci. 2002;15:1937-1952. (Pubitemid 35471884)
35. Verovski VN, Van den Berge DL, Soete GA, et al. Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside. Br J Cancer. 1996;74:1734-1742. (Pubitemid 26401892)
36. Trauzold A,Wermann H, Arlt A, et al. Cd95 and trail receptorYmediated activation of protein kinase C and NFJB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene. 2001;20:4258-4269. (Pubitemid 32762200)
37. Xiong HQ. Molecular targeting therapy for pancreatic cancer. Cancer Chemother Pharmacol. 2004;54(suppl 1):S69-S77. (Pubitemid 39517752)
38. Igney FH, Krammer PH. Death and anti-death: Tumour resistance to apoptosis. Nat Rev Cancer. 2002;2:277-288. (Pubitemid 37328781)
39. Arlt A, Vorndamm J, Breitenbroich M, et al. Inhibition of NFJB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (vp16) or doxorubicin. Oncogene. 2001;20:859-868. (Pubitemid 32198179)
40. Piva R, Belardo G, Santoro MG. NFJB: A stress-regulated switch for cell survival. Antioxid Redox Signal. 2006;8:478-486. (Pubitemid 43741316)
41. Salvesen GS, Duckett CS. IAP proteins: Blocking the road to death's door. Nat Rev Mol Cell Biol. 2002;3:401-410. (Pubitemid 34685698)
42. Cao C, Mu Y, Hallahan DE, et al. Xiap and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene. 2004;23:7047-7052. (Pubitemid 39319166)
43. Lu B, Mu Y, Cao C, et al. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Res. 2004;64:2840-2845. (Pubitemid 38500623)
44. Rodel C, Haas J, Groth A, et al. Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: Survivin as a radioresistance factor. Int J Radiat Oncol Biol Phys. 2003;55:1341-1347. (Pubitemid 36338302)
45. Giagkousiklidis S, Vogler M, Westhoff MA, et al. Sensitization for F-irradiationYinduced apoptosis by second mitochondria-derived activator of caspase. Cancer Res. 2005;65:10502-10513. (Pubitemid 41743746)
46. Nakanishi C, Toi M. Nuclear factor-JB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer. 2005;5:297-309. (Pubitemid 40488635)
47. Ravi R, Bedi A. NFJB in cancerVa friend turned foe. Drug Resist Updat. 2004;7:53-67. (Pubitemid 38453836)